Brain cell transplant aims to restore movement in Parkinson's patients

NCT ID NCT07212088

First seen Oct 31, 2025 · Last updated May 07, 2026 · Updated 37 times

Summary

This early-stage trial tests whether injecting lab-grown dopamine-producing cells into the brain is safe for people with advanced Parkinson's disease. The study involves 12 participants aged 55-75 who have had Parkinson's for over 5 years and experience medication complications. The goal is to see if this cell replacement can improve motor function and quality of life, though participants will still need ongoing medication.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310009, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.